tiprankstipranks
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
US Market

Bolt Biotherapeutics (BOLT) Income Statement

Compare
212 Followers

Bolt Biotherapeutics Income Statement

Last quarter (Q3 2024), Bolt Biotherapeutics's total revenue was $1.14M, a decrease of -54.87% from the same quarter last year. In Q3, Bolt Biotherapeutics's net income was $-15.18M. See Bolt Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 7.88M$ 5.73M$ 1.26M$ 231.00K$ 215.00K
Gross Profit
$ 5.99M$ 838.00K$ -2.41M$ -40.13M$ -25.79M
Operating Expenses
$ 84.07M$ 96.05M$ 94.05M$ 49.41M$ 31.18M
Depreciation and Amortization
$ 1.85M$ 4.89M$ 3.67M$ 2.50M$ 1.33M
EBITDA
$ -74.34M$ -88.66M$ -91.59M$ -48.57M$ -30.63M
Operating Income
$ -76.20M$ -90.32M$ -92.79M$ -49.18M$ -30.97M
Other Income/Expenses
$ 7.00M$ 2.22M$ -5.80M$ -11.55M$ 482.00K
Pretax Income
$ -69.20M$ -88.10M$ -98.59M$ -60.73M$ -30.49M
Net Income
$ -69.20M$ -85.88M$ -104.39M$ -72.27M$ -30.00M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.83$ -2.30$ -2.79$ -1.99$ -0.85
Diluted EPS
$ -1.83$ -2.30$ -2.79$ -1.99$ -0.85
Weighted Average Shares Outstanding
37.81M 37.36M 37.40M 36.25M 35.10M
Weighted Average Shares Outstanding (Diluted)
37.81M 37.36M 37.40M 36.25M 35.10M
Currency in USD

Bolt Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis